Hwang, W., Dearden, C., Loh, Y., Linn, Y., Tien, S., Teoh, G., . . . S'PORE, D. G. M. S. (2016). Outpatient-based therapy of oral fludarabine and subcutaneous alemtuzumab for asian patients with relapsed/refractory chronic lymphocytic leukemia.
استشهاد بنمط شيكاغوHwang, W.Y.K., et al. Outpatient-based Therapy of Oral Fludarabine and Subcutaneous Alemtuzumab for Asian Patients With Relapsed/refractory Chronic Lymphocytic Leukemia. 2016.
MLA استشهادHwang, W.Y.K., et al. Outpatient-based Therapy of Oral Fludarabine and Subcutaneous Alemtuzumab for Asian Patients With Relapsed/refractory Chronic Lymphocytic Leukemia. 2016.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.